Skip to main content
Clinical Trials/NL-OMON53099
NL-OMON53099
Recruiting
Not Applicable

Identifying subgroups with High cArdiovascular Risk in Breast cancer survivORs (HARBOR) - HARBOR

Antoni van Leeuwenhoek Ziekenhuis0 sites628 target enrollmentTBD

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
heart failure
Sponsor
Antoni van Leeuwenhoek Ziekenhuis
Enrollment
628
Status
Recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Observational invasive

Investigators

Sponsor
Antoni van Leeuwenhoek Ziekenhuis

Eligibility Criteria

Inclusion Criteria

  • \- early invasive BC (TNM stage I \- III);
  • \- diagnosed and/or treated in the AVL or UMCG;
  • \- treated 5 \- 7 years or 10 \- 12 years ago;
  • \- aged 40\-50 years at time of therapy;
  • \- signed written informed consent.

Exclusion Criteria

  • \- history of RT or CT unrelated to BC;
  • \- currently under treatment for BC recurrence or second malignancy (including
  • contralateral BC) other than non\-melanomatous skin cancer or curatively treated
  • carcinoma in situ of the cervix;
  • \- history of cardiac disease (CHF, acute coronary syndrome, coronary
  • revascularization procedure, symptomatic valvular dysfunction, cardiomyopathy
  • or congenital heart defect) before diagnosis and treatment for BC;
  • \- mental disability or psychological condition potentially hampering compliance
  • with the study protocol;
  • \- insufficient understanding of the Dutch language.

Outcomes

Primary Outcomes

Not specified

Similar Trials